Furthermore, ABT-263 and ABT-737 induce apoptosis in prostate cancer, hepatocellular carcinoma, colon cancer, and glioblastoma when combined with TRAIL [29, 39, 41, 42]. This evidence concerns the gene TNFSF10 and prostate carcinoma.